0.77
0.57%
-0.005
前日終値:
$0.775
開ける:
$0.76
24時間の取引高:
229.84K
Relative Volume:
0.31
時価総額:
$97.09M
収益:
$140.46M
当期純損益:
$-146.34M
株価収益率:
-0.5833
EPS:
-1.32
ネットキャッシュフロー:
$-117.73M
1週間 パフォーマンス:
-7.97%
1か月 パフォーマンス:
-9.81%
6か月 パフォーマンス:
-31.20%
1年 パフォーマンス:
+4.39%
Karyopharm Therapeutics Inc Stock (KPTI) Company Profile
名前
Karyopharm Therapeutics Inc
セクター
電話
617-658-0600
住所
85 WELLS AVENUE, NEWTON, MA
KPTI を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
KPTI | 0.77 | 97.09M | 140.46M | -146.34M | -117.73M | -1.32 |
VRTX | 449.35 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 749.23 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 588.75 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 247.29 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 107.11 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-01-19 | 開始されました | Piper Sandler | Overweight |
2022-11-04 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2022-02-09 | アップグレード | JP Morgan | Underweight → Neutral |
2021-11-19 | 再開されました | Morgan Stanley | Equal-Weight |
2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
2021-08-06 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
2021-08-06 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2020-07-02 | 開始されました | Morgan Stanley | Overweight |
2020-03-04 | 開始されました | Barclays | Overweight |
2020-01-17 | ダウングレード | Wedbush | Outperform → Neutral |
2019-07-23 | アップグレード | JP Morgan | Neutral → Overweight |
2019-07-05 | 繰り返されました | H.C. Wainwright | Buy |
2019-07-05 | 繰り返されました | Robert W. Baird | Outperform |
2019-03-01 | ダウングレード | JP Morgan | Overweight → Neutral |
2019-02-28 | 繰り返されました | BofA/Merrill | Underperform |
2019-02-27 | ダウングレード | BofA/Merrill | Neutral → Underperform |
2019-01-03 | アップグレード | BofA/Merrill | Underperform → Neutral |
2018-12-03 | 開始されました | B. Riley FBR | Buy |
2018-11-09 | アップグレード | Wedbush | Neutral → Outperform |
2018-05-24 | ダウングレード | Wedbush | Outperform → Neutral |
2018-04-02 | 再開されました | Leerink Partners | Outperform |
2017-11-15 | 再開されました | H.C. Wainwright | Buy |
2017-09-15 | 開始されました | RBC Capital Mkts | Outperform |
2016-09-08 | 繰り返されました | H.C. Wainwright | Buy |
2016-08-30 | アップグレード | Jefferies | Hold → Buy |
2016-08-18 | 開始されました | H.C. Wainwright | Buy |
2016-06-28 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Karyopharm Therapeutics Inc (KPTI) 最新ニュース
Karyopharm gains after changes to late-stage trial - MSN
Karyopharm appoints new chief accounting officer - Investing.com India
Karyopharm Therapeutics Appoints New Chief Accounting Officer - TipRanks
Karyopharm appoints Kristin Abate as Chief Accounting Officer - TipRanks
Karyopharm appoints new chief accounting officer By Investing.com - Investing.com UK
Karyopharm Therapeutics Inc. Appoints Kristin Abate as Chief Accounting Officer - Marketscreener.com
Karyopharm to Present New Selinexor Clinical Data at ASH 2024 Annual Meeting | KPTI Stock News - StockTitan
Avidity Partners Management LP's Strategic Acquisition of Karyop - GuruFocus.com
Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress By Investing.com - Investing.com Nigeria
Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress - Investing.com India
Karyopharm Therapeutics (NASDAQ:KPTI) Stock Rating Upgraded by StockNews.com - MarketBeat
GSA Capital Partners LLP Purchases 792,283 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat
Leerink Partnrs Issues Optimistic Forecast for KPTI Earnings - MarketBeat
What is HC Wainwright's Estimate for KPTI FY2024 Earnings? - MarketBeat
Karyopharm Therapeutics Falls To US$0.88, But Insiders Sold At Lower Price - Simply Wall St
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance
Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World
Karyopharm Therapeutics Reports Q3 2024 Financial Results and Corporate Progress - Defense World
Karyopharm Therapeutics Inc (KPTI) Is Worth Accumulating At Current Levels - Stocks Register
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2024 Earnings Call Transcript - Insider Monkey
Karyopharm stock price target raised, overweight on revenue beat - Investing.com India
Karyopharm therapeutics CEO Richard Paulson sells $3,346 in stock - Investing.com
Karyopharm therapeutics CEO Richard Paulson sells $3,346 in stock By Investing.com - Investing.com Canada
Karyopharm stock price target raised, overweight on revenue beat By Investing.com - Investing.com Australia
Earnings call: Karyopharm Therapeutics reports on clinical and financial progress - Investing.com Nigeria
Piper Sandler Boosts Karyopharm Therapeutics (NASDAQ:KPTI) Price Target to $5.00 - MarketBeat
Karyopharm price target raised to $5 from $4 at Piper Sandler - TipRanks
Karyopharm Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlig - GuruFocus.com
Karyopharm Therapeutics' SWOT analysis: oncology firm's stock faces pivotal year - Investing.com Australia
Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... - Yahoo Finance
Karyopharm Therapeutics Inc. Reports Q3 2024 Earnings - TipRanks
Karyopharm Therapeutics Q3 2024 Earnings Preview - MSN
Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript - AOL
Karyopharm Therapeutics: Q3 Earnings Snapshot - San Francisco Chronicle
Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings: EPS Loss of - GuruFocus.com
Karyopharm Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Karyopharm Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress - PR Newswire
Karyopharm Therapeutics Inc (KPTI) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
KPTIKaryopharm Therapeutics Inc. Latest Stock News & Market Updates - StockTitan
Karyopharm Therapeutics (KPTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - MSN
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - WV News
Karyopharm Therapeutics (KPTI) to Release Quarterly Earnings on Tuesday - MarketBeat
Karyopharm Therapeutics' (KPTI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Karyopharm updates SENTRY trial endpoints, eyes 2025 data - Investing.com India
Karyopharm updates SENTRY trial endpoints, eyes 2025 data By Investing.com - Investing.com Canada
Karyopharm stock gains as late-stage trial changes (KPTI:NASDAQ) - Seeking Alpha
Karyopharm Therapeutics Inc (KPTI) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):